| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/07/2009 | EP1499277B1 Pyy3-36 for the reduction or prevention of obesity |
| 01/07/2009 | EP1492511B1 Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
| 01/07/2009 | EP1478389B1 Treatment for diseases of the eye |
| 01/07/2009 | EP1471940B1 Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitisers |
| 01/07/2009 | EP1470113B1 Pyrimidinone viral polymerase inhibitors |
| 01/07/2009 | EP1456196B1 Benzothiophenes as adenosine receptor modulators |
| 01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
| 01/07/2009 | EP1425277B1 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 01/07/2009 | EP1406641B1 Krill extracts for prevention and/or treatment of cardiovascular diseases |
| 01/07/2009 | EP1392662B1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 01/07/2009 | EP1357909B1 Il-8 receptor antagonists |
| 01/07/2009 | EP1345896B1 Crystalline forms of atorvastatin |
| 01/07/2009 | EP1341521B1 Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers |
| 01/07/2009 | EP1333024B1 Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 01/07/2009 | EP1292300B1 Combinations od dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment fo diabete mellitus |
| 01/07/2009 | EP1251818B9 Galenic formulation |
| 01/07/2009 | EP1246835B1 Substituted sapogenins and their use |
| 01/07/2009 | EP1218361B1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 01/07/2009 | EP1204665B1 Chemokine receptor antagonists and methods of use therefor |
| 01/07/2009 | EP1200590B1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 01/07/2009 | EP1170005B1 Use of sesquiterpene alcohol for regulating the autonomic nervous system |
| 01/07/2009 | EP1135114B1 Method for reducing free-radical induced injury in vitro |
| 01/07/2009 | EP1127065B1 Chlamydia antigen and corresponding dna fragments and uses thereof |
| 01/07/2009 | EP0975223B1 In-situ generation of zinc pyrithione |
| 01/07/2009 | EP0971693B1 Method of making microencapsulated dna for vaccination and gene therapy |
| 01/07/2009 | EP0966537B1 Fasciola hepatica vaccines |
| 01/07/2009 | EP0966298B1 Pharmaceutical compositions for the treatment of the eye |
| 01/07/2009 | EP0870046B1 Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis |
| 01/07/2009 | EP0662827B2 Diagnostic methods and pharmaceutical compositions based on notch proteins and nucleic acids |
| 01/07/2009 | CN101341254A Process for the production of trans-10, cis 12 octadecadienoic acid |
| 01/07/2009 | CN101341246A The use of sirnas in organ storage/reperfusion solutions |
| 01/07/2009 | CN101341161A Bis-platinum complexes with antitumor activity |
| 01/07/2009 | CN101341160A Process for production of water-soluble azole prodrug |
| 01/07/2009 | CN101341154A Thienopyridine derivatives as modulators of metabotropic glutamate receptors |
| 01/07/2009 | CN101341153A New compounds |
| 01/07/2009 | CN101341152A New compounds |
| 01/07/2009 | CN101341151A Diazepinones |
| 01/07/2009 | CN101341150A Nitroimidazole compounds |
| 01/07/2009 | CN101341149A Chromane substituted benzimidazoles and their use as acid pump inhibitors |
| 01/07/2009 | CN101341148A New salt and polymorph of DPP-IV inhibitor |
| 01/07/2009 | CN101341147A Substituted heterocyclic compounds with cxcr3 antagonist activity |
| 01/07/2009 | CN101341146A 3- (4- { [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl[oxy] phenyl) -1-piperidinyl carbonyl }-1-naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of infla |
| 01/07/2009 | CN101341145A Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer |
| 01/07/2009 | CN101341143A Inhibitors of CCR9 activity |
| 01/07/2009 | CN101341142A Inhibitors of CCR9 activity |
| 01/07/2009 | CN101341140A Benzochromene derivatives for use in liquid crystal media and as therapeutic active substances |
| 01/07/2009 | CN101341138A Cyclic anilino-pyridinotriazines as GSK-3 inhibitors |
| 01/07/2009 | CN101341137A Pyrazine derivatives as epithelial sodium channel blocker |
| 01/07/2009 | CN101341135A Novel substituted pyrazinone derivatives for use in MCH-1 mediated diseases |
| 01/07/2009 | CN101341134A 嘧啶衍生物 Pyrimidine derivatives |
| 01/07/2009 | CN101341133A Quinazoline derivatives, process for their preparation and their use as anti-cancer agents |
| 01/07/2009 | CN101341132A Tosylate salt of 6- (4-br0m0-2-chl0r0phenylamin0) -7-fluoro-n- (2-hydroxyethoxy) -3-methyl-3h-benzimi dazole- 5 - carboxamide , mek inhibitor useful in the treatment of cancer |
| 01/07/2009 | CN101341131A Imidazoles as gaba-b receptor modulators |
| 01/07/2009 | CN101341130A Imidazole derivatives for the treatment of gastrointestinal disorders |
| 01/07/2009 | CN101341128A Pyrazoles for the treatment of gerd and ibs |
| 01/07/2009 | CN101341127A 4,5-dihydro- (1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators |
| 01/07/2009 | CN101341125A New phenanthridine derivatives as bradykinin antagonists |
| 01/07/2009 | CN101341124A Six-membered heterocycles useful as serine protease inhibitors |
| 01/07/2009 | CN101341123A 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 01/07/2009 | CN101341121A Inhibitors of CCR9 activity |
| 01/07/2009 | CN101340947A Combination of an iap-inhibitor and a taxane7 |
| 01/07/2009 | CN101340946A Pharmaceutical combination for the treatment of luts |
| 01/07/2009 | CN101340931A Modulation of tlr-mediated immune responses using adaptor oligonucleotides |
| 01/07/2009 | CN101340920A Anti-gastritis and anti-ulcer agent containing momordicae semen extract and momordica saponin i isolated from the same |
| 01/07/2009 | CN101340919A Method of treating clostridium difficile-associated diarrhea |
| 01/07/2009 | CN101340918A Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof |
| 01/07/2009 | CN101340917A Methods of treating gastrointestinal tract infections with tigecycline |
| 01/07/2009 | CN101340916A Preparation for external use having improved temporal stability of steroid |
| 01/07/2009 | CN101340915A Method for preventive hormonal contraception on demand |
| 01/07/2009 | CN101340914A Reduction of side effects from aromatase inhibitors used for treating breast cancer |
| 01/07/2009 | CN101340913A Agent for preventing or treating pancreas cancer, ovary cancer or liver cancer containing novel water-soluble prodrug |
| 01/07/2009 | CN101340912A (indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating rho kinase-mediated diseases and conditions |
| 01/07/2009 | CN101340911A Antitussive agent |
| 01/07/2009 | CN101340910A Treatment of drug-resistant tumors |
| 01/07/2009 | CN101340909A Method of inhibiting flt3 kinase |
| 01/07/2009 | CN101340908A Compositions and methods for treating cns disorders |
| 01/07/2009 | CN101340907A Diazonamide a analog |
| 01/07/2009 | CN101340906A Therapeutic agent or therapeutic method for ischemic stroke |
| 01/07/2009 | CN101340905A Oral preparation for preventing or improving skin dryness |
| 01/07/2009 | CN101340904A Compositions for peritoneal dialysis |
| 01/07/2009 | CN101340903A Combinations of metformin and meglitinide |
| 01/07/2009 | CN101340902A Materials and methods for treating viral infections with a cysteamine compound |
| 01/07/2009 | CN101340901A Control of cci-779 dosage form stability through control of drug substance impurities |
| 01/07/2009 | CN101340899A Orally disintegrating tablet comprising fat-soluble substance |
| 01/07/2009 | CN101340897A Orally disintegrating tablet of lansoprazole |
| 01/07/2009 | CN101340896A Compressed solid dosage form containing low soluble medicament and preparation thereof |
| 01/07/2009 | CN101340895A Oral formulations comprising tigecycline |
| 01/07/2009 | CN101340894A Bursting pellets |
| 01/07/2009 | CN101340889A Improved oral compositions comprising zinc citrate and/or tocopherol agents |
| 01/07/2009 | CN101340882A Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol |
| 01/07/2009 | CN101338036A Biocompatible quick-gelatinizing hydrogels and method for preparing spray thereof |
| 01/07/2009 | CN101338004A Sterilization polymer and preparation process thereof |
| 01/07/2009 | CN101337987A Anti-cataract target protein |
| 01/07/2009 | CN101337984A Bearberry type pentacyclic triterpenes amino acid derivates, method for preparing same and pharmaceutical use thereof |
| 01/07/2009 | CN101337980A Ruthenium complexes for restraining DNA from topologizing isomerase , preparation method and application thereof |
| 01/07/2009 | CN101337967A Mouth cavity articles, preparation method thereof and applications thereof |
| 01/07/2009 | CN101337957A Scutellarin derivates, preparation method and application thereof |
| 01/07/2009 | CN101337956A Scutellarein carbamate derivates, preparation method and application thereof |
| 01/07/2009 | CN101337948A 1,5-benzothiazepines compounds, preparation method and application thereof |
| 01/07/2009 | CN101337933A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |